Defronzo RA - Search Results

1

Two-step approach for the prediction of future type 2 diabetes risk.

Abdul-Ghani MA, Abdul-Ghani T, Stern MP, Karavic J, Tuomi T, Bo I, Defronzo RA, Groop L. Abdul-Ghani MA, et al. Among authors: defronzo ra. Diabetes Care. 2011 Sep;34(9):2108-12. doi: 10.2337/dc10-2201. Epub 2011 Jul 25. Diabetes Care. 2011. PMID: 21788628 Free PMC article.

2

Recombinant human insulin-like growth factor I treatment for 1 week improves metabolic control in type 2 diabetes by ameliorating hepatic and muscle insulin resistance.

Cusi K, DeFronzo R. Cusi K, et al. J Clin Endocrinol Metab. 2000 Sep;85(9):3077-84. doi: 10.1210/jcem.85.9.6827. J Clin Endocrinol Metab. 2000. PMID: 10999789 Clinical Trial.

3

Normalization of plasma glucose concentration by insulin therapy improves insulin-stimulated glycogen synthesis in type 2 diabetes.

Pratipanawatr T, Cusi K, Ngo P, Pratipanawatr W, Mandarino LJ, DeFronzo RA. Pratipanawatr T, et al. Among authors: defronzo ra. Diabetes. 2002 Feb;51(2):462-8. doi: 10.2337/diabetes.51.2.462. Diabetes. 2002. PMID: 11812756

4

Dose-response effect of pioglitazone on insulin sensitivity and insulin secretion in type 2 diabetes.

Miyazaki Y, Matsuda M, DeFronzo RA. Miyazaki Y, et al. Among authors: defronzo ra. Diabetes Care. 2002 Mar;25(3):517-23. doi: 10.2337/diacare.25.3.517. Diabetes Care. 2002. PMID: 11874940 Clinical Trial.

5

Free fatty acids reduce splanchnic and peripheral glucose uptake in patients with type 2 diabetes.

Bajaj M, Pratipanawatr T, Berria R, Pratipanawatr W, Kashyap S, Cusi K, Mandarino L, DeFronzo RA. Bajaj M, et al. Among authors: defronzo ra. Diabetes. 2002 Oct;51(10):3043-8. doi: 10.2337/diabetes.51.10.3043. Diabetes. 2002. PMID: 12351445 Clinical Trial.

6

Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus.

Miyazaki Y, Glass L, Triplitt C, Wajcberg E, Mandarino LJ, DeFronzo RA. Miyazaki Y, et al. Among authors: defronzo ra. Am J Physiol Endocrinol Metab. 2002 Dec;283(6):E1135-43. doi: 10.1152/ajpendo.0327.2001. Am J Physiol Endocrinol Metab. 2002. PMID: 12424102 Free article. Clinical Trial.

7

Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients.

Miyazaki Y, Pipek R, Mandarino LJ, DeFronzo RA. Miyazaki Y, et al. Among authors: defronzo ra. Int J Obes Relat Metab Disord. 2003 Jan;27(1):88-94. doi: 10.1038/sj.ijo.0802187. Int J Obes Relat Metab Disord. 2003. PMID: 12532159

8

Further evidence for a type 2 diabetes susceptibility locus on chromosome 11q.

Duggirala R, Almasy L, Blangero J, Jenkinson CP, Arya R, DeFronzo RA, Stern MP, O'Connell P; American Diabetes Association GENNID Study Group. Duggirala R, et al. Among authors: defronzo ra. Genet Epidemiol. 2003 Apr;24(3):240-2. doi: 10.1002/gepi.10233. Genet Epidemiol. 2003. PMID: 12652528 No abstract available.

9

Analysis of metabolic parameters as predictors of risk in the RENAAL study.

Appel GB, Radhakrishnan J, Avram MM, DeFronzo RA, Escobar-Jimenez F, Campos MM, Burgess E, Hille DA, Dickson TZ, Shahinfar S, Brenner BM; RENAAL Study. Appel GB, et al. Among authors: defronzo ra. Diabetes Care. 2003 May;26(5):1402-7. doi: 10.2337/diacare.26.5.1402. Diabetes Care. 2003. PMID: 12716796

10

Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes.

Bajaj M, Suraamornkul S, Pratipanawatr T, Hardies LJ, Pratipanawatr W, Glass L, Cersosimo E, Miyazaki Y, DeFronzo RA. Bajaj M, et al. Among authors: defronzo ra. Diabetes. 2003 Jun;52(6):1364-70. doi: 10.2337/diabetes.52.6.1364. Diabetes. 2003. PMID: 12765945

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

669 results

Search Page